Print

Protalix Biotherapeutics, Inc. (PLX) to Present at the UBS Global Life Sciences Conference  
9/12/2012 10:02:26 AM

CARMIEL, Israel, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE:PLX) (TASE:PLX), announced today that Dr. David Aviezer, the Company's President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Thursday, September 20, 2012 at 8:00 AM ET at the Grand Hyatt Hotel in New York City. A live webcast of the presentation will be available at www.protalix.com on the event calendar page. A replay will be archived and available after the conclusion of the presentation for 30 days.
//-->